Jan Birger Fredrik Toernell
Director/Miembro de la Junta en ABLIVA AB .
Cargos activos de Jan Birger Fredrik Toernell
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ABLIVA AB | Director/Miembro de la Junta | 27/04/2017 | - |
| Independent Dir/Board Member | 27/04/2017 | - | |
| University of Gothenburg | Corporate Officer/Principal | - | - |
| Sahlgrenska University | Corporate Officer/Principal | - | - |
Innoext AB
 Innoext AB Miscellaneous Commercial ServicesCommercial Services Innoext AB provides management consulting services. The private company is based in Västra Frölunda, Sweden. Jan Birger Fredrik Toernell has been the CEO of the Swedish company since 2011. | Director/Miembro de la Junta | 01/07/2011 | - |
| Director Ejecutivo | 01/07/2011 | - | |
| Lidds Pharma AB | Corporate Officer/Principal | - | - |
Aqilion AB
 Aqilion AB Investment ManagersFinance Aqilion AB is a venture capital firm. The firm was founded in 2002 by Jan Ekberg and Mats G. Ringesten. It's headquartered in Helsingborg, Sweden. | Inversor de Capital Privado | 29/05/2012 | - |
Glactone Pharma AB
 Glactone Pharma AB Pharmaceuticals: MajorHealth Technology Glactone Pharma AB engages in the development of pipeline of novel signal transducer and activator of transcription 3 inhibitors. Its pipeline is used for immuno-oncology and for the treatment of drug resistant cancers, including castration resistant prostate cancer. The company was founded by Anders Sigvard Bjartell, Rebecka Hellsten, Martin Johansson, Eduardo Munoz, and Olov Arvid Sterner in 2012 and is headquartered in Helsingborg, Sweden. | Presidente | 01/07/2012 | - |
| Stayble AB | Director/Miembro de la Junta | - | - |
Diaprost AB
 Diaprost AB Miscellaneous Commercial ServicesCommercial Services Diaprost AB is a private pharmaceutical research and development company based in Lund, Sweden. Diaprost collaborates with leading international experts in the fields of molecular medicine, biotechnology, immunology, radiology, radiation physics, laboratory medicine, and oncology. The Swedish company has an agreement with a top 10 pharma company for its first antibody H11B6 targeting the HK2 antigen, which is in early clinical development. The remaining Diaprost pipeline consists of 5A10, which targets free-PSA antigen for both diagnostic and therapeutic applications. The company was founded in 2005 with the aim of leveraging the transformative success of the PSA assay for detection of prostate cancer as a personalized theranostic platform. Johan Drott has been the CEO of the company since 2015. | Director/Miembro de la Junta | 01/06/2012 | - |
| ░░░░░░ ░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - | - |
| ░░░░░░░░ | - | - | |
| ░░░░░░░░ ░░░░░░ ░░░░░░░░░░░ ░░ | ░░░░░░░░ | - | - |
Historial de carrera de Jan Birger Fredrik Toernell
Antiguos cargos conocidos de Jan Birger Fredrik Toernell.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░░ ░░░░░░░ ░░ | ░░░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - | |
| ░░░░░░░ ░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░░░░ ░░░░░░░ ░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - | - |
| ░░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░░░ ░░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░░░░ ░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░ ░░ | ░░░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | - | - |
Formación de Jan Birger Fredrik Toernell.
| University of Gothenburg | Doctorate Degree |
Estadísticas
Internacional
| Suecia | 19 |
| Reino Unido | 2 |
Operativa
| Director/Board Member | 6 |
| Chairman | 5 |
| Corporate Officer/Principal | 5 |
Sectorial
| Health Technology | 9 |
| Commercial Services | 3 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 5 |
|---|---|
| LIDDS AB | Health Technology |
| STAYBLE THERAPEUTICS AB | Health Technology |
| ASTRAZENECA PLC | Health Technology |
| ABLIVA AB | Health Technology |
| ISOFOL MEDICAL AB | Health Technology |
| Empresas privadas | 12 |
|---|---|
Aqilion AB
Aqilion AB Investment ManagersFinance Aqilion AB is a venture capital firm. The firm was founded in 2002 by Jan Ekberg and Mats G. Ringesten. It's headquartered in Helsingborg, Sweden. | Finance |
| Glactone Pharma Development AB | |
| Innoex AB | |
Diaprost AB
Diaprost AB Miscellaneous Commercial ServicesCommercial Services Diaprost AB is a private pharmaceutical research and development company based in Lund, Sweden. Diaprost collaborates with leading international experts in the fields of molecular medicine, biotechnology, immunology, radiology, radiation physics, laboratory medicine, and oncology. The Swedish company has an agreement with a top 10 pharma company for its first antibody H11B6 targeting the HK2 antigen, which is in early clinical development. The remaining Diaprost pipeline consists of 5A10, which targets free-PSA antigen for both diagnostic and therapeutic applications. The company was founded in 2005 with the aim of leveraging the transformative success of the PSA assay for detection of prostate cancer as a personalized theranostic platform. Johan Drott has been the CEO of the company since 2015. | Commercial Services |
| Stayble AB | |
Oncorena AB
 Oncorena AB Pharmaceuticals: MajorHealth Technology Oncorena AB develops a novel pharmacological treatment for metastatic renal clear cell cancer. It conducts clinical trial for potential new therapies in humans. The company was founded in 2011 and is headquartered in Helsingborg, Sweden. | Health Technology |
Glactone Pharma AB
Glactone Pharma AB Pharmaceuticals: MajorHealth Technology Glactone Pharma AB engages in the development of pipeline of novel signal transducer and activator of transcription 3 inhibitors. Its pipeline is used for immuno-oncology and for the treatment of drug resistant cancers, including castration resistant prostate cancer. The company was founded by Anders Sigvard Bjartell, Rebecka Hellsten, Martin Johansson, Eduardo Munoz, and Olov Arvid Sterner in 2012 and is headquartered in Helsingborg, Sweden. | Health Technology |
Oncorena Holding AB
 Oncorena Holding AB Pharmaceuticals: MajorHealth Technology Oncorena Holding AB develops novel pharmacological treatment for metastatic renal clear cell cancer. It conducts clinical trial for potential new therapies. The company was founded by Björn Oskar Larsson in 2011 and is headquartered in Helsingborg, Sweden. | Health Technology |
| Lidds Pharma AB | |
Innoext AB
Innoext AB Miscellaneous Commercial ServicesCommercial Services Innoext AB provides management consulting services. The private company is based in Västra Frölunda, Sweden. Jan Birger Fredrik Toernell has been the CEO of the Swedish company since 2011. | Commercial Services |
Hammars Bryggeri AB
 Hammars Bryggeri AB Beverages: AlcoholicConsumer Non-Durables Hammars Bryggeri AB engages in brewery operations. It produces a wide range of soft drinks, water, and other cider beverages. The company was founded in 1904 and is headquartered in Hammar, Sweden. | Consumer Non-Durables |
Puls AB
 Puls AB Environmental ServicesIndustrial Services Puls AB is a Swedish company that specializes in sewage, industrial, and environmental services. Puls is located in Staffanstorp, Sweden and is known as the largest player in va maintenance in southern Sweden. The private company offers on-call assistance for a range of issues, including emergency stops in the drain and remediation after accidents. The company provides services such as sewage cleaning, wastewater flushing, and water blasting to clean tanks, cisterns, sheet metal, boat hulls, and more in an environmentally friendly manner. The company has a team of talented employees who specialize in water and wastewater services for tenant-owner associations, offering maintenance and emergency measures. | Industrial Services |
